Tumor antigen and process for the preparation thereof
CA 1077840 A · Owner: Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. · Inventors: Modolell, Manuel; Munder, Paul G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the disclosure:, The present invention relates to tumor antigens which can be obtained from tumor cells by treating tumor cells with a short chain synthetic lysolecithin analog separating the, cell residue and recovering the supernatant; the invention relates furthermore to immunotherapeutic medicaments against tumor affections which consist of or contain the tumor antigens obtained according to the above process.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 20, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 20, 1997.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.